S66 — Star Combo Pharma Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsSpeculativeMicro CapSuper Stock

Annual balance sheet for Star Combo Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	Interim Report
Standards:	AAS	AAS	AAS	AAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	17.3	10.4	9.49	7.36	18.1
Net Total Accounts Receivable
Net Total Receivables	4.45	3.18	4.3	4.48	2.38
Total Inventory
Total Other Current Assets
Total Current Assets	26.4	19.1	18.1	18.4	25.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.5	22.7	22.7	23.1	21.6
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	43.3	43.4	42.2	42.8	48.5
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.55	4.01	4.33	4.87	5.86
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	7.13	8.04	9.13	9.49	10.4
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	36.2	35.4	33.1	33.3	38.1
Total Liabilities & Shareholders' Equity	43.3	43.4	42.2	42.8	48.5
Total Common Shares Outstanding